An MS Prodrome? Really?

Volume 5, Issue 7

An MS Prodrome? Really?

In this issue:

Is there an MS “prodrome” — a period before the onset of clinical symptoms? If it exists, what are its characteristics? How can it be identified and measured? What is its predictive value? What does the current evidence show? These are some of the questions Dr. Naila Makhani from the Yale School of Medicine discusses in this issue of eMultipleSclerosis Review.

Learning objectives:

Appraise the quality of evidence that support the existence of a multiple sclerosis prodrome.
Discuss new data characterizing radiologically isolated syndrome in children and adults.

Author:

Naila Makhani, MD, MPH

Associate Professor of Pediatrics and Neurology
Yale School of Medicine
New Haven, CT

Guest Faculty Disclosures

Dr. Makhani has indicated that she has no financial interests in or relationships with a commercial entity. 

Unlabeled/Unapproved Uses

Dr. Makhani has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.  

Program Directors:

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Guest Faculty Disclosures:

Dr. Makhani has indicated that she has no financial interests in or relationships with a commercial entity. 

Unlabeled/Unapproved Uses:

Dr. Makhani has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.  

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: September 13, 2023
Expiration date: September 12, 2025

Start Issue